Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
12.50
+0.09 (0.73%)
May 13, 2025, 4:00 PM - Market closed
Embecta Employees
Embecta had 2,100 employees as of September 30, 2024. The number of employees decreased by 100 or -4.55% compared to the previous year.
Employees
2,100
Change (1Y)
-100
Growth (1Y)
-4.55%
Revenue / Employee
$514,048
Profits / Employee
$25,143
Market Cap
730.53M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 2,100 | -100 | -4.55% |
| Sep 30, 2023 | 2,200 | 300 | 15.79% |
| Sep 30, 2022 | 1,900 | -129 | -6.36% |
| Sep 30, 2021 | 2,029 | -298 | -12.81% |
| Sep 30, 2020 | 2,327 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EMBC News
- 4 days ago - Embecta Corp. (EMBC) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results - GlobeNewsWire
- 5 days ago - embecta Announces Quarterly Cash Dividend - GlobeNewsWire
- 15 days ago - Embecta to host Analyst and Investor Day on May 22, 2025 - GlobeNewsWire
- 22 days ago - embecta to Report Fiscal Second Quarter 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations - GlobeNewsWire
- 2 months ago - Embecta: Weak Outlook But Mouth-Watering Valuation Skew Risk-Reward In Favour - Seeking Alpha
- 3 months ago - embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference - GlobeNewsWire